Cleared Traditional

Disposable Endoscopic Cutter Stapler and Cartridge (K211197) - FDA 510(k) Clearance

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K211197 · Changzhou Waston Medical Appliance Co., Ltd. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2023
Decision
638d
Days
Class 2
Risk

K211197 is an FDA 510(k) clearance for the Disposable Endoscopic Cutter Stapler and Cartridge. Classified as Staple, Implantable (product code GDW), Class II - Special Controls.

Submitted by Changzhou Waston Medical Appliance Co., Ltd. (Changzhou, CN). The FDA issued a Cleared decision on January 19, 2023 after a review of 638 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4750 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General & Plastic Surgery submissions.

View all Changzhou Waston Medical Appliance Co., Ltd. devices

Submission Details

510(k) Number K211197 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 21, 2021
Decision Date January 19, 2023
Days to Decision 638 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
523d slower than avg
Panel avg: 115d · This submission: 638d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GDW Staple, Implantable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Consultant

Mid-Link Consulting Co, Ltd.
Diana Hong

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - GDW Staple, Implantable

All 128
Devices cleared under the same product code (GDW) and FDA review panel - the closest regulatory comparables to K211197.
Anika Tissue Tack Fixation System
K222487 · Anika Therapeutics, Inc. · May 2023
AEON Endoscopic Stapler
K222210 · Lexington Medical, Inc. · Apr 2023
ECHELON LINEAR™ 60 mm Cutter (GLC60)
K223760 · Ethicon Endo-Surgery · Mar 2023
EEA Circular Stapler with Tri-Staple Technology
K221771 · Covidien · Nov 2022
Signia™ Small Diameter Reloads Including Regular (Round) Tip Version
K222641 · Covidien · Nov 2022
Autosuture EEA Stapler / circular stapler with DST Series Technology / EEA Autosuture Circular Stapler with DST Series Technology / DST Series EEA Stapler / DST EEA
K221003 · Covidien · Sep 2022